John Trusheim

RGD peptide in cancer targeting: Benefits, challenges, solutions, and possible integrin–RGD interactions

Glioblastoma Therapy: Past, Present and Future

A state-of-the-art review and guidelines for tumor treating fields treatment planning and patient follow-up in glioblastoma

Cilengitide in patients with newly diagnosed glioblastoma multiforme and unmethylated MGMT gene promoter: Protocol of a multicenter, randomized, open-label, controlled phase II study.